Laparoscopic Lateral Suspension With Mesh & Sacrocervicopexy for the Treatment of Uterine Prolapse
A Multicenter, Randomized, Prospective, Controlled Study Comparing Uterine Preserving Laparoscopic Lateral Suspension With Mesh Versus Laparoscopic Sacrocervicopexy in the Treatment of Uterine Prolapse: A Randomized Controlled Trial
Fatih Sultan Mehmet Training and Research Hospital
This study is aimed to compare the efficiency of two uterus-preserving laparoscopic methods to treat uterine prolapse in a randomized controlled trial. Laparoscopic lateral suspension with mesh (LLSM) will be compared with laparoscopic sacrohysteropexy (LS). Both procedures are known as sufficient uterus preserving methods. LLSM was introduced to be an alternative to others with avoiding dissection of promontory and therefore being safer, faster and feasible technique.
Registry Overview
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Recruitment status
completed
Actual enrollment (reported)
44 participants
Study completion date
March 14, 2019
Actual (reported)
Listed locations
1 countries · 2 sites
Trial Relationships
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Related Scientific Literature
Loading related publications...
Study Timeline
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
Pelvic Organ ProlapseTranslabial ultrasoundTransperineal ultrasoundLateral Mesh SuspensionDescensus uteriLaparoscopic pelvic organ prolapse repairUterus preservinghysteropexyuterine-preservingfertility-sparingsacropexycervicopexysacrocervicopexysacrohysteropexymesh prolapse surgery
Outcome Measures
Primary Outcomes (1)
Change from baseline POP-Q measurements (mm) at 12th month.
Prolapse degree; Point Ba/C/Bp
12 months for each participant
Secondary Outcomes (11)
Subjective Success - Change from baseline Female Sexual Function Index (FSFI) to measure sexual dysfunction at 12th month.
12 months for each participant
Subjective Success - Change from baseline Michigan Incontinence Severity Index (M-ISI) to measure urinary incontinence at 12th month.
12 months for each participant
Study Arms (2)
Lateral suspension
EXPERIMENTAL
"Uterus-preserving Laparoscopic lateral suspension with mesh" technique will be performed in this arm.
Procedure: Uterus-preserving laparoscopic lateral suspension with mesh
Sacrocervicopexy
EXPERIMENTAL
"Uterus-preserving Laparoscopic sacrocervicopexy with mesh" technique will be performed in this arm.
Procedure: Uterus-preserving laparoscopic sacrocervicopexy with mesh
Interventions
Uterus-preserving laparoscopic lateral suspension with meshProcedure
V-shaped 2cm wide and 25cm length mesh strip is prepared from a 30x30cm Prolene mesh (Ethicon J\&J).Deep dissection of the uterovesical space is performed.Cutaneous incisions are bilaterally made 3-4 cm superoposterior to the anterosuperior iliac spine.A grasper is introduced retroperitoneally through the sub-peritoneum holding the beginning part of mesh until reaching the vesicovaginal space in an oblique route rather than transverse.Round ligament is lifted upward and tunnel is practiced horizontally.Assistant grasper catches the distal mesh and pulls out through the opposite subperitoneal tunnel.Corner of mesh is fixed to the pubocervical fascia,uterine cervix and isthmus with Absorba-Tack™(Covidien, Mansfield,USA).Tension-free lateral mesh suspension is achieved at the desired level.
Lateral suspension
Uterus-preserving laparoscopic sacrocervicopexy with mesh
Eligibility Criteria
Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
You may qualify if:
\>18 years old
\> Symptomatic prolapse of central compartment with a Pelvic Organ Prolapse Quantitative (POP-Q) stage 2 associated or not with anterior or posterior compartment prolapse.
Fatih Sultan Mehmet Training and Research Hospital, Sancaktepe Campus
Istanbul, Sancaktepe, 34785, Turkey (Türkiye)
Sisli Hamidiye Etfal Training and Research Hospital
Istanbul, Sisli, 34371, Turkey (Türkiye)
Related Publications (1)
Veit-Rubin N, Dubuisson JB, Gayet-Ageron A, Lange S, Eperon I, Dubuisson J. Patient satisfaction after laparoscopic lateral suspension with mesh for pelvic organ prolapse: outcome report of a continuous series of 417 patients. Int Urogynecol J. 2017 Nov;28(11):1685-1693. doi: 10.1007/s00192-017-3327-2. Epub 2017 Apr 17.
ProlapsePathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases
Intervention Hierarchy (Ancestors)
Study Officials
Niyazi Tug, As.Prof.
Chief of the Department
STUDY DIRECTOR
Enrollment
44 participants (actual enrollment reported by the registry).
Study Design
Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
Care provider will be blind to the operation type. Outcomes will be assessed by a gynecologist who will be blind to the operation type, indications and complications. Assessor has wide experience in urogynecological sonography.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator
Study Record Dates
First Submitted
January 21, 2018
First Posted
February 5, 2018
Study Start
NCT03221725
The Development of De-novo Stress Urinary Incontinence After Stage II-III Pelvic Organ Prolapse Surgery
Subjective Success - Change from baseline Prolapse Quality of Life questionnaire (PQoL) to measure quality of life according to pelvic organ prolapse at 12th month.
12 months for each participant
Subjective Success - Change from baseline Pelvic Organ Prolapse Symptom Score (POP-SS) to measure quality of life according to pelvic organ prolapse at 12th month.
12 months for each participant
Subjective Success - Change from baseline Visual Analog Score (VAS) for pain at 12th month.
12 months for each participant
+6 more secondary outcomes
Procedure
The peritoneum over the sacral promontory is incised until the anterior longitudinal ligament is reached and ureters are identified. Peritoneal relaxing incision is made medial to the right ureter, down into the pelvis, posterior to the cervix and rectovaginal fascia, laterally to the rectum. The arm of the mesh is sutured to the posterior cervix by 2.0 prolene and fixated to the sacral promontory by either Tacker (Covidien) and/or 2.0 prolene as tension-free. Complete peritonisation of the mesh is performed.
Sacrocervicopexy
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Patients who are not comfortable with using or refusing pessary
Wish to preserve the uterus
You may not qualify if:
Any cue for gynecologic oncological condition
Patients who approves Le Fort colpocleisis among who does not have any sexual intercourse
Contact the study team to confirm eligibility.
MelanocortinsPro-OpiomelanocortinHypothalamic HormonesPeptide HormonesHormonesHormones, Hormone Substitutes, and Hormone AntagonistsPituitary Hormones, AnteriorPituitary HormonesNeuropeptidesPeptidesAmino Acids, Peptides, and ProteinsNerve Tissue ProteinsProteins
January 24, 2018
Actual (reported)
Primary Completion
March 14, 2019
Actual (reported)
Study Completion
March 14, 2019
Actual (reported)
Last Updated
March 18, 2019
Record last verified: 2019-03
Data Sharing
IPD Sharing
Will not share
Study Protocol
Source record
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.